Results 171 to 180 of about 343,983 (293)

UK Medical Cannabis Registry: A Two-Year Prospective Observational Cohort Study of Clinical Outcomes in Insomnia. [PDF]

Neuropsychopharmacol Rep
Koye A, Erridge S, Clarke E, McLachlan K, Coomber R, Rucker JJ, Weatherall MW, Sodergren MH.   +7 more
europepmc   +1 more source

Changes in the transition from cannabis use to use disorder by decade of first use: Findings from the Australian National Mental Health and Wellbeing surveys

Addiction, EarlyView.
Abstract Background and aims As cannabis becomes increasingly accessible and products more potent, it is critical that we understand how this may impact the risk of transitioning from cannabis use to cannabis use disorder (CUD). We aimed to examine whether the risk and speed of transition from cannabis use to CUD differ by decade of first cannabis use.
Jack Wilson, Siobhan O'Dean, Christina Marel, Olivia Dobson, Matthew Sunderland, Steph Kershaw, Tara Gückel, Emma Krogh Devine, Tim Slade, Maree Teesson, Emily Stockings   +10 more
wiley   +1 more source

Potential Iatrogenic Harms From Medicinal Cannabis Prescribing in Australia: A Case Series. [PDF]

Drug Alcohol Rev
Bradlow R, Sorensen J, Cunningham A, Daugherty S, Hadinata E, Armstrong F, Jamshidi N.   +6 more
europepmc   +1 more source

Substance‐free and substance‐related reinforcement in relation to substance use: A meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Contemporary behavioral economic theory conceptualizes addiction as an operant reinforcer pathology in which substance use is substantively influenced by reinforcement obtained through substance‐free sources. The aim of the current meta‐analysis was to quantitatively synthesize cross‐sectional associations between both ...
Brian M. Bird, Molly L. Garber, Samuele F. Acuff, Keanan J. Joyner, James G. Murphy, James MacKillop   +5 more
wiley   +1 more source

Sociodemographic Trends in Daily, Weekly and Less Than Weekly Cannabis Use in Australia. [PDF]

Drug Alcohol Rev
Leung J, Chan GCK, Zhang R, Hall WD, McClure-Thomas C.   +4 more
europepmc   +1 more source

Drug use disorders among people convicted of large‐, moderate‐ and small‐scale drug supply crimes: A register‐based retrospective comparative study

Addiction, EarlyView.
Abstract Background and aims Heavy drug use has been associated with small‐scale drug crime, but the substance use histories of individuals involved in the manufacturing, smuggling and wholesaling of larger quantities of drugs [here referred to as serious drug crimes (SDC)] have been largely unexamined.
Julie Elizabeth Brummer, Freja Ilsing Magnussen, Morten Hesse, Thomas Friis Søgaard   +3 more
wiley   +1 more source

Regulation and Use of Cannabidiol in Croatia Compared with Selected European and International Models: From Consumer Products to Clinical Practice. [PDF]

J Clin Med
Batinic A, Zecic A, Dujic Z, Sutlovic D.
europepmc   +1 more source

When psychedelic discourse meets local narrative: Selective uptake of psychedelic meanings surrounding mad honey in Nepal

Addiction, EarlyView.
Abstract Aims ‘Mad honey’ is produced when bees collect nectar from Rhododendron species containing grayanotoxins, naturally occurring diterpenoid toxins that can produce dose‐dependent intoxication. It has long been embedded in Nepalese medicinal and ritual practices but has recently become part of global psychedelic discourse. This study examined how
Sharon R. Sznitman, Surendra Tiwari
wiley   +1 more source

Polygenic prediction of cannabis‐related outcomes: Evidence from the Avon Longitudinal Study of Parents and Children longitudinal cohort and the European gene–environment interaction case–control study

Addiction, EarlyView.
Abstract Background and aims Polygenic risk scores (PRSs) for cannabis use disorder (CUD), major depressive disorder (MDD), insomnia and chronic pain, and early age at cannabis initiation might be linked to problematic cannabis use. We tested whether: (1) higher PRS for CUD, MDD, insomnia and chronic pain are associated with earlier initiation and ...
Edoardo Spinazzola, Isabelle Austin‐Zimmerman, Giulia Trotta, Zhikun Li, Perry B. M. Leung, Edward Chesney, Qiang Li, Luis Alameda, Celso Arango, Michael O'Donovan, Jim van Os, Pak C. Sham, Craig Morgan, Evangelos Vassos, Diego Quattrone, Tom Freeman, Marta Di Forti, Robin M. Murray   +17 more
wiley   +1 more source

Chronic pain treatment experiences and barriers among opioid agonist treatment participants who inject drugs: A qualitative study

Addiction, EarlyView.
Abstract Background and aim Co‐occurring chronic pain affects nearly half of people receiving opioid use disorder (OUD) treatment. Although this pain is often severe, it is usually inadequately managed. Stigma and clinical complexity associated with OUD are thought to further restrict access to pain care.
Jie Yang, Shelley Walker, Amy G. McNeilage, Peter Higgs, Louisa Picco, Paul Dietze, Suzanne Nielsen   +6 more
wiley   +1 more source